Search Results - Shenghai Xing
- Showing 1 - 1 results of 1
-
1
Cost-Effectiveness of Apatinib and Cabozantinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer by Bo Shi, Wenbiao Ma, Hongshuai Pan, Yang Shi, Huan Zhang, Shenghai Xing
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book